SensoDetect AB is a Sweden-based company within healthcare sector. Its primary product SensoDetect BERA is a tool for investigation of brainstem function. It measures brainstem activity and provides brainstem audiometry measuring the brain’s response to sound. Brainstem audiogram of a patient is compared to the ones of healthy persons and discrepancy areas are related to psychiatric diagnoses schizophrenia and attention deficit hyperactivity disorder (ADHD). The product is designed for such areas as psychiatry, pharmaceutical industry and research. The Company’s primary markets comprise the United Kingdom, Germany, Sweden and Bolivia. The main shareholders are Avanza Pension and Nordnet Pensionsforsakring.